Amarin plans another fight against concentrated EPA supplements
Supplement RegulationsAmarin plans another fight against concentrated EPA supplementsAmarin plans another fight against concentrated EPA supplements
Amarin, the manufacturer of the pharmaceutical drug Vascepa, has devised a new strategy in its long-running grievances against the dietary supplement sector.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.